These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 3824694)
21. Tumor behavior in transitional cell carcinoma of the bladder in relation to chromosomal markers and histopathology. Babu VR; Lutz MD; Miles BJ; Farah RN; Weiss L; Van Dyke DL Cancer Res; 1987 Dec; 47(24 Pt 1):6800-5. PubMed ID: 3479251 [TBL] [Abstract][Full Text] [Related]
23. Prognosis in early carcinoma of the bladder based on chromosomal analysis. Falor WH; Ward RM J Urol; 1978 Jan; 119(1):44-8. PubMed ID: 621813 [TBL] [Abstract][Full Text] [Related]
24. [Spectral karyotyping of seven prenatally detected marker chromosomes and complex chromosome aberrations]. Song HL; Chen BJ; Fang Q; Xie YJ; Lin SB; Wu JZ Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Aug; 29(4):393-7. PubMed ID: 22875493 [TBL] [Abstract][Full Text] [Related]
25. Cytogenetic characterization of the murine bladder cancer model MB49 and the derived invasive line MB49-I. Fabris VT; Lodillinsky C; Pampena MB; Belgorosky D; Lanari C; Eiján AM Cancer Genet; 2012 Apr; 205(4):168-76. PubMed ID: 22559978 [TBL] [Abstract][Full Text] [Related]
26. In vivo assessment of urinary bladder malignancy. Karr JP; Pontes JE; Murphy GP; Gibas Z; Sandberg AA Prog Clin Biol Res; 1984; 162A():331-46. PubMed ID: 6592614 [No Abstract] [Full Text] [Related]
27. A routine method for cytogenetic analysis of small urinary bladder tumor biopsies. Fraser C; Sullivan LD; Kalousek DK Cancer Genet Cytogenet; 1987 Nov; 29(1):103-8. PubMed ID: 3664443 [TBL] [Abstract][Full Text] [Related]
28. Chromosomal analysis of bladder cancer. II. A practical method. Smeets W; Pauwels R; Laarakkers L; Debruyne F; Geraedts J Cancer Genet Cytogenet; 1987 Nov; 29(1):23-7. PubMed ID: 3664446 [TBL] [Abstract][Full Text] [Related]
29. Noninvasive detection of alterations in chromosome numbers in urinary bladder cancer cells, using fluorescence in situ hybridization. Okamura T; Umemoto Y; Yasui T; Saiki S; Kuroda H; Kotoh S; Kamizaki H Int J Clin Oncol; 2004 Oct; 9(5):373-7. PubMed ID: 15549587 [TBL] [Abstract][Full Text] [Related]
30. Abnormal chromosomes and number 1 heterochromatin variants revealed in C-banded preparations from 13 bladder carcinomas. Atkin NB; Baker MC Cytobios; 1977; 18(70):101-9. PubMed ID: 610999 [TBL] [Abstract][Full Text] [Related]
31. [Clinical case of tandem translocation between chromosomes 13 and 15]. Badalian LO; Arkhipov BA; Malygina NA; Patrukhin AS; Lysov VL Tsitol Genet; 1985; 19(4):304-8. PubMed ID: 4049521 [TBL] [Abstract][Full Text] [Related]
32. Protruding chromosome arms in histological sections of tumours with large marker chromosomes. Brandão HJ; Atkin NB Br J Cancer; 1968 Jun; 22(2):184-91. PubMed ID: 4873187 [No Abstract] [Full Text] [Related]
34. Structural chromosome 1 aberrations in transitional cell carcinoma of the bladder: interphase cytogenetics combining a centromeric, telomeric, and library DNA probe. Poddighe PJ; Ramaekers FC; Smeets AW; Vooijs GP; Hopman AH Cancer Res; 1992 Sep; 52(18):4929-34. PubMed ID: 1516049 [TBL] [Abstract][Full Text] [Related]
35. Human urinary bladder carcinoma cell line (T24) in long-term culture: chromosomal studies on a wild population and derived sublines. Malkovský M; Bubeník Neoplasma; 1977; 24(3):319-26. PubMed ID: 895941 [TBL] [Abstract][Full Text] [Related]
36. Recurrent cytogenetic aberrations in human ovarian carcinomas. Kiechle-Schwarz M; Bauknecht T; Schmidt J; Walz L; Pfleiderer A Cancer Detect Prev; 1995; 19(3):234-43. PubMed ID: 7750111 [TBL] [Abstract][Full Text] [Related]
37. Ring chromosomes in bladder cancer. Milasin J; Mićić M; Mićić S; Diklić V Cancer Genet Cytogenet; 1987 Sep; 28(1):183-4. PubMed ID: 3607736 [No Abstract] [Full Text] [Related]
38. Double minutes and homogeneously staining regions: gene amplification in mammalian cells. Cowell JK Annu Rev Genet; 1982; 16():21-59. PubMed ID: 6760799 [No Abstract] [Full Text] [Related]
39. Toward the validation of aneusomy detection by fluorescence in situ hybridization in bladder cancer: comparative analysis with cytology, cytogenetics, and clinical features predicts recurrence and defines clinical testing limitations. Zhang FF; Arber DA; Wilson TG; Kawachi MH; Slovak ML Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2317-28. PubMed ID: 9815630 [TBL] [Abstract][Full Text] [Related]